Uncategorized
i-ExoCraft® Platform: World’s First AI-Driven Exosome Design & Manufacturing Platform
The world's first AI-driven Exosome Design House platform for integrated exosome design and manufacturing. Tailored for multidimensional scenarios across aesthetics, skincare, and precision medicine, it analyzes miRNA and proteomic profiles for functional prediction, delivering evidence-based, patented, and differentiated products for clients.
International Certification: Industry-Leading Number of Exosome INCI Registrations
Demonstrating international R&D capabilities, we have successfully obtained 6 exosome INCI (International Nomenclature of Cosmetic Ingredients) registrations covering multiple cell sources, including human AFSCs. We provide flexible and diverse ingredient formulation solutions to fully empower the innovative development of premium skincare products.
GTP-Grade Cell banking: Exclusive AFSC Isolation & 20-Year Cryopreservation
In our high-specification GTP laboratory certified by the Taiwan FDA (TFDA), we provide exclusive amniotic fluid stem cell isolation and purification services for expectant mothers, along with up to 20 years of liquid nitrogen cryopreservation, seamlessly connecting to diverse personalized regenerative medicine and product applications.
Amniotic Fluid Stem Cell Exosomes (AFSC-EXO): Rich in Diverse Bioactivity
Accordingtoa 2025 study from the University of Oxford, amniotic fluid exosomes contain a richer and more diverse miRNA profile than umbilical cord stem cell exosomes, demonstrating superior bioactivity and efficacy in regulating tissue regeneration, anti-inflammation, and anti-fibrosis.